During the past decade, Klinik Ottakring conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik Ottakring" #1 sponsor was "Bayer" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Ottakring" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Klinik Ottakring" are "Acute Myocardial Infarction" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Transitional Cell" (1 trials). Many other conditions were trialed in "Klinik Ottakring" in a lesser frequency.

Most popular intervention types in "Klinik Ottakring" are "Drug" (11 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Bendamustine" (2 trials), "Placebo" (2 trials), "Venetoclax" (2 trials) and "Alpelisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Ottakring" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinik Ottakring". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Klinik Ottakring, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Ottakring, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".